12:00 AM
May 16, 2013
 |  BC Innovations  |  Distillery Therapeutics

Indication: Cancer

This week in therapeutics
Indication Target/marker/pathway Summary Licensing status Publication and contact information
Cancer Insulin receptor substrate 1 (IRS1); phosphatidylinositol 3-kinase catalytic subunit a-polypeptide (PIK3CA; p110a); phosphoinositide 3-kinase-a (PI3Ka) Cell...

Read the full 246 word article

User Sign in

Trial Subscription

Get a 4-week free trial subscription to BioCentury Innovations

Article Purchase

$35 USD
More Info >